DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Acunzo J, Thirion S, Roche C. et al.
Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas.
Cancer Res 2008;
68: 10163-10170 10.1158/0008-5472.can-08-1857
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.